PurposeThe management of advanced or recurrent prostate cancer is limited in part by the lack of effective imaging agents. Metabolic changes in prostate cancer have previously been exploited for imaging, culminating in the recent US FDA approval of [11C]choline for the detection of subclinical recurrent disease after definitive local therapy. Despite this milestone, production of [11C]choline requires an on-site cyclotron, limiting the scope of medical centers at which this scan can be offered. In this pilot study, we tested whether prostate cancer could be imaged with positron emission tomography (PET) using [68Ga]citrate, a radiotracer that targets iron metabolism but is produced without a cyclotron.ProceduresEight patients with castrate-...
CONTEXT Radiolabelled choline positron emission tomography has changed the management of prostate...
BACKGROUND: Accurate staging of patients with prostate cancer (PCa) is important for therapeutic dec...
BACKGROUND: Preclinical and histological data show overexpression of the type 1 cannabinoid receptor...
PURPOSE: 68Ga ligands targeting prostate-specific membrane antigen (PSMA) are rapidly emerging as a ...
Introduction: One of the most important parameter in prostate cancer diagnostics is fast and accurat...
Objective: To assess the impact of a novel molecular imaging technique, 68Ga-(HBED-CC)-prostate-spec...
none4noNowadays several new imaging modalities are available for investigating prostate cancer (PCa)...
Noninvasive biomarkers that detect the activity of important oncogenic drivers could significantly i...
PURPOSE: Prostate-specific membrane antigen (PSMA)-targeted PET/CT has become increasingly important...
Aim: To evaluate the use of PET/CT with 64CuCl2 in recurring prostate cancer after surgery in patien...
International audienceAim/Introduction: The aim of this retrospective study was to investigate the i...
Prostate cancer (PCa) is the most common non-cutaneous malignancy in men and the leading cause of ca...
Purpose: Radio-recurrent prostate cancer is typically detected by a rising prostate-specific antigen...
Prostate cancer and its treatment have taken a prominent place in western health care systems. In pa...
AIM: To assess the utility of (11)C-choline PET/CT in the restaging of prostate cancer (PC) patients...
CONTEXT Radiolabelled choline positron emission tomography has changed the management of prostate...
BACKGROUND: Accurate staging of patients with prostate cancer (PCa) is important for therapeutic dec...
BACKGROUND: Preclinical and histological data show overexpression of the type 1 cannabinoid receptor...
PURPOSE: 68Ga ligands targeting prostate-specific membrane antigen (PSMA) are rapidly emerging as a ...
Introduction: One of the most important parameter in prostate cancer diagnostics is fast and accurat...
Objective: To assess the impact of a novel molecular imaging technique, 68Ga-(HBED-CC)-prostate-spec...
none4noNowadays several new imaging modalities are available for investigating prostate cancer (PCa)...
Noninvasive biomarkers that detect the activity of important oncogenic drivers could significantly i...
PURPOSE: Prostate-specific membrane antigen (PSMA)-targeted PET/CT has become increasingly important...
Aim: To evaluate the use of PET/CT with 64CuCl2 in recurring prostate cancer after surgery in patien...
International audienceAim/Introduction: The aim of this retrospective study was to investigate the i...
Prostate cancer (PCa) is the most common non-cutaneous malignancy in men and the leading cause of ca...
Purpose: Radio-recurrent prostate cancer is typically detected by a rising prostate-specific antigen...
Prostate cancer and its treatment have taken a prominent place in western health care systems. In pa...
AIM: To assess the utility of (11)C-choline PET/CT in the restaging of prostate cancer (PC) patients...
CONTEXT Radiolabelled choline positron emission tomography has changed the management of prostate...
BACKGROUND: Accurate staging of patients with prostate cancer (PCa) is important for therapeutic dec...
BACKGROUND: Preclinical and histological data show overexpression of the type 1 cannabinoid receptor...